DE2714713C3 - Salpetersäureester von N-(2-HydroxyäthyO-nicotinamid, Verfahren zu dessen Herstellung und Arzneimittel - Google Patents

Salpetersäureester von N-(2-HydroxyäthyO-nicotinamid, Verfahren zu dessen Herstellung und Arzneimittel

Info

Publication number
DE2714713C3
DE2714713C3 DE2714713A DE2714713A DE2714713C3 DE 2714713 C3 DE2714713 C3 DE 2714713C3 DE 2714713 A DE2714713 A DE 2714713A DE 2714713 A DE2714713 A DE 2714713A DE 2714713 C3 DE2714713 C3 DE 2714713C3
Authority
DE
Germany
Prior art keywords
compound
coronary
dose
acid
nitric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2714713A
Other languages
German (de)
English (en)
Other versions
DE2714713B2 (de
DE2714713A1 (de
Inventor
Tatsuo Ohmiya Saitama Kujirai
Isao Tokio Matsunaga
Takashi Tama Tokio Mori
Hiroyuki Iwatsuki Saitama Nagano
Toshichika Tokio Ogasawara
Minoru Tokio Shindo
Shigeru Musashino Tokio Sugano
Sakae Ageo Saitama Takaku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP51036101A external-priority patent/JPS5817463B2/ja
Priority claimed from JP8245876A external-priority patent/JPS6052685B2/ja
Priority claimed from JP8352276A external-priority patent/JPS539775A/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE2714713A1 publication Critical patent/DE2714713A1/de
Publication of DE2714713B2 publication Critical patent/DE2714713B2/de
Application granted granted Critical
Publication of DE2714713C3 publication Critical patent/DE2714713C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE2714713A 1976-04-02 1977-04-01 Salpetersäureester von N-(2-HydroxyäthyO-nicotinamid, Verfahren zu dessen Herstellung und Arzneimittel Expired DE2714713C3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP51036101A JPS5817463B2 (ja) 1976-04-02 1976-04-02 ニコチン酸アミド誘導体
JP8245876A JPS6052685B2 (ja) 1976-07-13 1976-07-13 循環器疾患治療剤
JP8352276A JPS539775A (en) 1976-07-15 1976-07-15 Pyridine derivatives and their preparation

Publications (3)

Publication Number Publication Date
DE2714713A1 DE2714713A1 (de) 1977-10-20
DE2714713B2 DE2714713B2 (de) 1980-02-21
DE2714713C3 true DE2714713C3 (de) 1980-10-16

Family

ID=27288973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2714713A Expired DE2714713C3 (de) 1976-04-02 1977-04-01 Salpetersäureester von N-(2-HydroxyäthyO-nicotinamid, Verfahren zu dessen Herstellung und Arzneimittel

Country Status (13)

Country Link
AR (2) AR217423A1 (cg-RX-API-DMAC7.html)
AT (1) AT360532B (cg-RX-API-DMAC7.html)
AU (1) AU509591B2 (cg-RX-API-DMAC7.html)
CA (1) CA1088944A (cg-RX-API-DMAC7.html)
CH (1) CH633535A5 (cg-RX-API-DMAC7.html)
DE (1) DE2714713C3 (cg-RX-API-DMAC7.html)
DK (1) DK145608C (cg-RX-API-DMAC7.html)
ES (2) ES457421A1 (cg-RX-API-DMAC7.html)
FI (1) FI66598C (cg-RX-API-DMAC7.html)
FR (1) FR2346334A1 (cg-RX-API-DMAC7.html)
MX (1) MX5534E (cg-RX-API-DMAC7.html)
NL (2) NL176674C (cg-RX-API-DMAC7.html)
SE (1) SE436029B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
AU3693789A (en) * 1988-05-10 1989-11-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) New ophthalmic preparation for treating glaucoma
US4973565A (en) * 1989-07-17 1990-11-27 Corning Incorporated Fluoroborosilicate glass and clad article
ZA91291B (en) * 1990-01-16 1991-09-25 Hoechst Ag Di(nitroxyalkyl)amides of pyridine-2,4-and-2,5-dicarboxylic acids,a process for the preparation thereof,and the use thereof
AU4841700A (en) * 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
PL2307380T3 (pl) * 2008-07-01 2013-01-31 Univ Jagiellonski Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego
IT1403890B1 (it) 2010-12-28 2013-11-08 Procos Spa Processo per la produzione di nicorandil

Also Published As

Publication number Publication date
AR217423A1 (es) 1980-03-31
ES457421A1 (es) 1978-11-16
FI66598B (fi) 1984-07-31
NL176674B (nl) 1984-12-17
AR220907A1 (es) 1980-12-15
DE2714713B2 (de) 1980-02-21
FI66598C (fi) 1984-11-12
DE2714713A1 (de) 1977-10-20
ES468462A1 (es) 1979-10-01
FR2346334A1 (fr) 1977-10-28
AU509591B2 (en) 1980-05-15
SE7703868L (sv) 1977-10-03
NL176674C (nl) 1985-05-17
NL930042I2 (nl) 1993-09-16
MX5534E (es) 1983-09-27
AU2353277A (en) 1978-09-28
DK145608B (da) 1982-12-27
CH633535A5 (en) 1982-12-15
NL7703624A (nl) 1977-10-04
SE436029B (sv) 1984-11-05
ATA235077A (de) 1980-06-15
DK128277A (da) 1977-10-03
CA1088944A (en) 1980-11-04
FI771024A7 (cg-RX-API-DMAC7.html) 1977-10-03
FR2346334B1 (cg-RX-API-DMAC7.html) 1980-02-01
NL930042I1 (nl) 1993-08-02
DK145608C (da) 1983-07-11
AT360532B (de) 1981-01-12

Similar Documents

Publication Publication Date Title
US4200640A (en) Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
DE2557438C2 (cg-RX-API-DMAC7.html)
DE69014351T2 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DE2846251C2 (cg-RX-API-DMAC7.html)
DE2736784A1 (de) N-substituierte und nichtsubstituierte hexahydro-6-canthinonderivate, verfahren zum herstellen derselben und diese derivate enthaltende pharmazeutische zusammensetzung
DE2714713C3 (de) Salpetersäureester von N-(2-HydroxyäthyO-nicotinamid, Verfahren zu dessen Herstellung und Arzneimittel
DE3005580A1 (de) Guanidinobenzoesaeurederivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
EP0038438A2 (de) Substituierte 1,2,5-Oxadiazol-2-oxide zur Anwendung als Arzneimittel und sie enthaltende Arzneimittel
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
CH647505A5 (de) Taurinderivate, verfahren zu deren herstellung und arzneimittel, welche diese verbindungen enthalten.
DE3314878C2 (cg-RX-API-DMAC7.html)
EP0054873B1 (de) 3,4-Disubstituierte 1,2,5-Oxadiazol-2-oxide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE1470216C3 (de) 4-Diisopropylamino-2-pheny l-2-(2pyridyl)-butyramid, dessen pharmakologisch verträgliche Säureadditionssalze sowie Verfahren zu ihrer Herstellung
DE2719607C2 (cg-RX-API-DMAC7.html)
DE3810264C2 (cg-RX-API-DMAC7.html)
DE2322561A1 (de) Trisubstituierte imidazole
DE2755016C2 (cg-RX-API-DMAC7.html)
DE1934392C3 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
DE2358466A1 (de) Chlorierte mandelsaeureamidin-derivate
CH641167A5 (en) N-Cyano-N'-(2-((4-methyl-5-imidazolyl)-methylthio)ethyl)-N''-alkyny l guanidines
WO2005084675A1 (de) Kv1.5-blocker zur selektiven steigerung der vorhofkontraktilität und behandlung der herzinsuffizienz
AT360536B (de) Verfahren zur herstellung des neuen salpeter- saeureesters von n-(2-hydroxyaethyl)nicotinamid und von dessen salzen
DE3324727C2 (cg-RX-API-DMAC7.html)
WO1996000715A1 (de) Neue [2-(3,4-dimethoxy-phenyl)-ethyl]-(2-phenoxy-ethyl)-amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT. HERMANN, G., DIPL.-PHYS. DR.RER.NAT. SCHMIDT, J., DIPL.-ING. JAENICHEN, H., DIPL.-BIOL. DR.RER.NAT., PAT.-ANWAELTE, 81675 MUENCHEN TREMMEL, H., RECHTSANW., 8000 MUENCHEN UEXKUELL-GUELDENBAND-MENZEL, A., DR.PHIL. (PH.D.), 82166 GRAEFELFING WEINBERGER, R., DIPL.-CHEM.UNIV. DR.RER.NAT., 81675 MUENCHEN BUBLAK, W., DIPL.-CHEM. UNIV., PAT.-ANWAELTE, 80997 MUENCHEN